Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Orphan drug pricing for non-orphan meds? Express Scripts is looking at you, Gilead
Fierce Pharma Marketing
Tuesday, October 28, 2014 - 6:59pm
tags:
drug pricing, Express Scripts, Gilead Sciences, Harvoni, Sovaldi
BDSI Developing Long-Acting Vaccine for Pain Treatment
Drug Discovery and Development
Tuesday, October 28, 2014 - 6:57pm
tags:
BioDelivery Sciences, vaccines, buprenorphine, painkillers
Ackman-Allergan Enters Courtroom Phase: Opening Line
Bloomberg
Tuesday, October 28, 2014 - 6:51pm
tags:
Bill Ackman, Allergan, Valeant Pharmaceuticals, M&A
Gilead third-quarter Sovaldi sales dip, but net profit triples
Yahoo/Reuters
Tuesday, October 28, 2014 - 6:49pm
tags:
Gilead Sciences, earnings
Sanofi Diabetes Outlook Signals an ‘Undisciplined’ Price War may Erupt
WSJ Pharmalot
Tuesday, October 28, 2014 - 1:57pm
tags:
Sanofi, diabetes, Eli Lilly
[video]Amgen CEO: We're not splitting up
CNBC
Tuesday, October 28, 2014 - 11:35am
tags:
Amgen, restructuring, Bob Bradway
FDA staff recommends limited use of Daiichi's blood thinner
Yahoo/Reuters
Tuesday, October 28, 2014 - 11:34am
tags:
Daiichi Sankyo, FDA, bloodthinners, edoxaban, atrial fibrillation
Amgen adds up to 1,100 new job cuts to its global restructuring plan
Fierce Biotech
Tuesday, October 28, 2014 - 10:35am
tags:
Amgen, layoffs, restructuring
Locking up Savings? Sovaldi Could be Cost Effective for Prisons: Study
WSJ Pharmalot
Tuesday, October 28, 2014 - 10:32am
tags:
Gilead Sciences, hepatitis C, Sovaldi, prisons
Amgen's stock rises after company outlines capital allocation plans
Marketwatch
Tuesday, October 28, 2014 - 10:30am
tags:
Amgen
Ebola: The making of a $1 billion drug
CNN Money
Tuesday, October 28, 2014 - 10:29am
tags:
ebola virus, GSK, NewLink Genetics, JNJ, government contracts, Bavarian Nordic
Bristol-Myers Squibb Enters into Agreement that Provides an Exclusive Option to Acquire F-star Alpha Ltd. and its Novel HER2-Targeted Therapy
Yahoo
Tuesday, October 28, 2014 - 10:28am
tags:
Bristol-Myers Squibb, F-star Alpha, breast cancer
Sanofi CEO Asks Board For Explanation Of Rumors Of His Ousting
Bidness Etc.
Tuesday, October 28, 2014 - 9:54am
tags:
Sanofi, Pharma CEOs, Chris Viehbacher
Sanofi Announces Mixed Financial Results, Warns Of Slowdown In Diabetes Drug Sales
Bidness Etc.
Tuesday, October 28, 2014 - 9:52am
tags:
Sanofi, earnings
Novartis chief says new heart failure drug will be a winner
Seeking Alpha
Tuesday, October 28, 2014 - 9:48am
tags:
Novartis, Joe Jimenez, heart failure, LCZ696
Medicines Co. prevails in patent challenge from Mylan
Seeking Alpha
Tuesday, October 28, 2014 - 9:45am
tags:
Medicines Company, patents, Mylan Labs, Angiomax
Could MannKind Corporation Be Running Out of Money?
NASDAQ.com
Tuesday, October 28, 2014 - 9:43am
tags:
MannKind
Ackman’s $5.3 Billion Allergan Bet Examined Before Vote
Bloomberg
Tuesday, October 28, 2014 - 8:58am
tags:
Bill Ackman, Allergan, Valeant Pharmaceuticals, M&A
Sanofi shares plunge after diabetes drug warning
Yahoo/AP
Tuesday, October 28, 2014 - 8:57am
tags:
Sanofi, diabetes, Lantus
Ranbaxy books first profit in six quarters on exclusive drug launch
Reuters
Tuesday, October 28, 2014 - 8:51am
tags:
Ranbaxy, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.